Viewing Study NCT05737160


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-03-07 @ 4:48 AM
Study NCT ID: NCT05737160
Status: COMPLETED
Last Update Posted: 2025-05-23
First Post: 2023-02-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Telitacicept in Generalized Myasthenia Gravis
Sponsor: RemeGen Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myasthenia Gravis, Generalized View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myasthenia Gravis View
None Autoimmune Diseases View
None Muscle Weakness View